The importance of chemotherapy and radiation in uterine papillary serous carcinoma

Gynecologic Oncology

Volumn 123, Issue 3, 2011, Pages 542-547

  Viswanathan, Akila N ^a   MacKlin, Eric A ^b   Berkowitz, Ross ^a   Matulonis, Ursula ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chemotherapy; Radiation therapy; Uterine papillary serous cancer

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

ADULT; AGED; AGING; ARTICLE; BLADDER TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; MYOMETRIUM; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RECTUM TOXICITY; RISK ASSESSMENT; TOXICITY; UTERINE PAPILLARY SEROUS CARCINOMA; UTERUS CARCINOMA; VAGINA TOXICITY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, PAPILLARY; COHORT STUDIES; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 81155148254     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.09.005     Document Type: Article

References (53)

1. W.T. Creasman, M.F. Kohler, F. Odicino, P. Maisonneuve, and P. Boyle Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium Gynecol Oncol 95 2004 593 596 (Pubitemid 39610410)
2. C.A. Hamilton, M.K. Cheung, and K. Osann Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers Br J Cancer 94 2006 642 646 (Pubitemid 43361894)
3. P.J. Eifel, J. Ross, M. Hendrickson, R.S. Cox, R. Kempson, and A. Martinez Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus: treatment comparisons Cancer 52 1983 1026 1031 (Pubitemid 13050768)
4. A.H. Frank, P.C. Tseng, and B.G. Haffty Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinoma Cancer 68 1991 1516 1519
5. G. Gitsch, M.L. Friedlander, G.V. Wain, and N.F. Hacker Uterine papillary serous carcinoma. A clinical study Cancer 75 1995 2239 2243
6. J. Grice, M. Ek, and B. Greer Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients Gynecol Oncol 69 1998 69 73 (Pubitemid 28201674)
7. P. Lim, A. Al Kushi, B. Gilks, F. Wong, and C. Aquino-Parsons Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome Cancer 91 2001 752 757 (Pubitemid 32173300)
8. P. Mallipeddi, D.S. Kapp, and N.N. Teng Long-term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma Cancer 71 1993 3076 3081 (Pubitemid 23145541)
9. N. Mehta, S.D. Yamada, J. Rotmensch, and A.J. Mundt Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy Int J Radiat Oncol Biol Phys 57 2003 1004 1009 (Pubitemid 37324118)
10. B.M. Slomovitz, T.W. Burke, and P.J. Eifel Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases Gynecol Oncol 91 2003 463 469 (Pubitemid 38388137)
11. R.S. Smith, D.S. Kapp, Q. Chen, and N.N. Teng Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy Int J Radiat Oncol Biol Phys 48 2000 767 778
12. N. Rochet, F. Sterzing, and A.D. Jensen Intensity-modulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study Int J Radiat Oncol Biol Phys 2009
13. B. DuBeshter, K. Estler, K. Altobelli, S. McDonald, C. Glantz, and C. Angel High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer Gynecol Oncol 94 2004 383 386 (Pubitemid 39024541)
14. E.C. Batchelor, J.M. Watkins, W.T. Creasman, M.F. Kohler, D. Sinha, and J.M. Jenrette The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma Eur J Obstet Gynecol Reprod Biol 141 2008 163 168
15. R.R. Barakat, G. Lev, and A.J. Hummer Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches Gynecol Oncol 105 2007 150 156 (Pubitemid 46441452)
16. A.N. Fader, R.D. Drake, and D.M. O'Malley Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma Cancer 115 2009 2119 2127
17. A.N. Fader, C. Nagel, and A.E. Axtell Stage II uterine papillary serous carcinoma: carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes Gynecol Oncol 112 2009 558 562
18. H. Goldberg, R.C. Miller, and R. Abdah-Bortnyak Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN) Gynecol Oncol 108 2008 298 305
19. P. Rosenberg, B. Boeryd, and E. Simonsen A new aggressive treatment approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer Gynecol Oncol 48 1993 32 37 (Pubitemid 23056183)
20. G.T. Bozas, A. Bamias, and E. Kastritis Adjuvant chemotherapy with paclitaxel and carboplatin in non-endometrioid carcinoma of the uterus Eur J Gynaecol Oncol 26 2005 627 631 (Pubitemid 43033067)
21. A. Alobaid, I. Bruchim, H. Verkooijen, P. Gauthier, and P. Petignat Adjuvant therapy for patients with stage I papillary serous endometrial cancer Eur J Surg Oncol 32 2006 358 362
22. J.T. Chambers, S.K. Chambers, E.I. Kohorn, M.L. Carcangiu, and P.E. Schwartz Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide Gynecol Oncol 60 1996 438 442 (Pubitemid 26077633)
23. C.S. Dietrich III, S.C. Modesitt, and P.D. DePriest The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC) Gynecol Oncol 99 2005 557 563 (Pubitemid 41686536)
24. D. Faratian, A. Stillie, R.M. Busby-Earle, V.J. Cowie, and H. Monaghan A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome Int J Gynecol Cancer 16 2006 972 978 (Pubitemid 43886712)
25. A.L. Fields, M.H. Einstein, A.P. Novetsky, J. Gebb, and G.L. Goldberg Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC) Gynecol Oncol 108 2008 201 206 (Pubitemid 350299448)
26. C.A. Hamilton, W.S. Liou, and K. Osann Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma Int J Radiat Oncol Biol Phys 63 2005 839 844 (Pubitemid 41400073)
27. C.A. Hamilton, M.K. Cheung, and K. Osann The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma Gynecol Oncol 103 2006 679 683 (Pubitemid 44602186)
28. L.J. Havrilesky, A.A. Secord, and V. Bae-Jump Outcomes in surgical stage I uterine papillary serous carcinoma Gynecol Oncol 105 2007 677 682 (Pubitemid 46734192)
29. M.G. Kelly, D.M. O'Malley, and P. Hui Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy Gynecol Oncol 98 2005 353 359 (Pubitemid 41169144)
30. M.G. Kelly, D. O'Malley, and P. Hui Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation Gynecol Oncol 95 2004 469 473 (Pubitemid 39592506)
31. J.S. Low, E.H. Wong, and H.S. Tan Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma Gynecol Oncol 97 2005 171 177 (Pubitemid 40403690)
32. H. Steed, L. Manchul, and B. Rosen Uterine papillary serous carcinoma: evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapy Int J Gynecol Cancer 16 Suppl 1 2006 278 285
33. M.B. Thomas, A. Mariani, W.A. Cliby, G.A. Keeney, K.C. Podratz, and S.C. Dowdy Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma Gynecol Oncol 107 2007 186 189 (Pubitemid 47575712)
34. K.M. Zanotti, J.L. Belinson, A.W. Kennedy, K.D. Webster, and M. Markman The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma Gynecol Oncol 74 1999 272 277 (Pubitemid 29377225)
35. M.E. Randall, V.L. Filiaci, and H. Muss Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study J Clin Oncol 24 2006 36 44 (Pubitemid 46630491)
36. T. Hogberg Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials Clin Oncol (R Coll Radiol) 2008
37. R. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
38. J. Fine, and R. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
39. L. Ramondetta, T.W. Burke, C. Levenback, M. Bevers, D. Bodurka-Bevers, and D.M. Gershenson Treatment of uterine papillary serous carcinoma with paclitaxel Gynecol Oncol 82 2001 156 161 (Pubitemid 32634969)
40. R. Maggi, A. Lissoni, and F. Spina Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial Br J Cancer 95 2006 266 271 (Pubitemid 44187586)
41. N. Susumu, S. Sagae, and Y. Udagawa Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study Gynecol Oncol 108 2008 226 233 (Pubitemid 350299451)
42. T. Hogberg, M. Signorelli, and C.F. de Oliveira Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer-results from two randomised studies Eur J Cancer 46 2010 2422 2431
43. J. Kwon, I. Ackerman, and E. Franssen The role of abdominal-pelvic radiotherapy in the management of uterine papillary serous carcinoma Int J Radiat Oncol Biol Phys 59 2004 1439 1445 (Pubitemid 38954066)
44. A.A. Martinez, S. Weiner, and K. Podratz Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation Gynecol Oncol 90 2003 537 546
45. G. Sutton, J.H. Axelrod, and B.N. Bundy Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study Gynecol Oncol 97 2005 755 763 (Pubitemid 40824643)
46. J. Aalders, V. Abeler, P. Kolstad, and M. Onsrud Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients Obstet Gynecol 56 1980 419 427 (Pubitemid 10018299)
47. C.L. Creutzberg, W.L. van Putten, and P.C. Koper Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 2000 1404 1411 (Pubitemid 30215963)
48. P. Blake, A.M. Swart, and J. Orton Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis Lancet 373 2009 137 146
49. H.M. Keys, J.A. Roberts, and V.L. Brunetto A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol Oncol 92 2004 744 751 (Pubitemid 38251372)
50. H. Kitchener, A.M. Swart, Q. Qian, C. Amos, and M.K. Parmar Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 2009 125 136
51. P. Benedetti Panici, S. Basile, and F. Maneschi Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial J Natl Cancer Inst 100 2008 1707 1716
52. N.R. Abu-Rustum, K. Alektiar, and A. Iasonos The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center Gynecol Oncol 103 2006 714 718 (Pubitemid 44602163)
53. K. Greven, K. Winter, K. Underhill, J. Fontenesci, J. Cooper, and T. Burke Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer Gynecol Oncol 103 2006 155 159 (Pubitemid 44374683)